Procter & Gamble Health Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec ' 25	Sep ' 25	Dec ' 24	Dec ' 23	Dec ' 22

Sales

698.78

663.66

623.18

614.90

607.52

Operating profit

230.73

210.61

237.47

190.31

201.20

Interest

0.22

0.24

0.30

0.37

0.39

Gross profit

239.82

219.35

244.41

201.17

208.77

EPS (Rs)

100.08

93.20

104.36

82.92

84.61

Other income

9.31

8.98

7.24

11.23

7.96

Stock adjustment

-8.34

-10.23

20.57

9.56

-26.28

Raw material

162.60

137.67

109.77

158.15

181.30

Power and fuel

-

-

-

-

-

Employee expenses

115.69

109.89

93.27

118.07

90.04

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

198.10

215.72

162.10

138.81

161.26

Provisions made

-

-

-

-

-

Depreciation

11.98

11.52

11.32

13.40

17.23

Taxation

61.71

53.11

59.86

50.13

51.08

Net profit / loss

166.13

154.72

173.23

137.64

140.46

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.60

16.60

16.60

16.60

16.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

33.02

31.73

38.11

30.95

33.12

GPM (%)

33.87

32.61

38.77

32.13

33.92

NPM (%)

23.46

23.00

27.48

21.98

22.82